Health

‘Vaccines don’t give 100 per cent protection’

‘Vaccines don’t give 100 per cent protection’

Dr. Nikhil Tandon, is Professor in the Department of Endocrinology and Metabolism at the All India Institute of Medical Sciences, and Head of Capacity Building at the Centre for Chronic Disease Control in New Delhi. His research interests include autoimmune thyroid disease which includes thyroid epidemiology, diabetes and metabolic bone disease, and the impact of early life events in adult chronic disease. In an interview to Swimmi Shrivastava, Dr Tandon talks about precautions everyone, especially people with diabetes and other comorbidities, should take to avoid a surge in the Covid-19 cases during the upcoming festival season. This second wave had…
Read More
WhatsApp helps vaccination slot booking

WhatsApp helps vaccination slot booking

The MyGov Corona Helpdesk on WhatsApp now allows users to locate their nearest vaccination centre and book their vaccine-appointment. The Ministry of Health and MyGov announced it. To contact MyGov Corona Helpdesk chatbot, citizens can save the WhatsApp number +91 9013151515 on their phones, start a chat by typing ‘Book Slot’ and send it to the number. This will generate a 6-digit one-time password on the respective mobile phone number. Users then choose a preferred date and location, based on the pincode and vaccine type. All users can follow this sequence to get a confirmation of their centre and day…
Read More
Glenmark Pharma achieves a world record

Glenmark Pharma achieves a world record

Glenmark Pharmaceuticals successfully achieved a world record for the largest pin badge sentence, 'Pride of India' on 18 August 2021, in Mumbai. A total of 22,373 Indian flag pin badges were used to create the sentence. Over 15,000 diabetologists, cardiologists and physicians from across the country participated and supported this unique initiative honouring the frontline warriors. This achievement is aimed to honour the healthcare warriors, who have been on the frontlines of the nation’s battle against COVID-19, safeguarding countrymen’s lives whilst risking theirs. Glenmark Pharmaceuticals is a pioneer in the Diabetes Care segment in India. It is the first company in…
Read More
Lupin’s Aptivate for children

Lupin’s Aptivate for children

During the peak of the second wave of Covid-19, almost 80,000 kids had tested positive across five states according to government data. There is still no approved vaccine available for children in India. So, immunity for the kid below 18 becomes a matter of paramount importance. Parents must ensure that their children are provided healthy nutritious food. Natural home remedies and time-tested ingredients like Giloy, Amla and Pippali that are also recommended by Ayush Mantralaya can be administered to help children build their natural immune system. Lupin’s Aptivate is an ayurvedic syrup that helps in improving appetite and mothers can…
Read More
SC notice on plea seeking transparency in vaccine clinical data

SC notice on plea seeking transparency in vaccine clinical data

The Supreme Court on Monday issued notice on a plea seeking transparency in clinical trial data for the vaccines being administered in India under emergency use authorization and also a stay on the vaccine mandates, which is being issued by authorities in various parts of the country. Advocate Prashant Bhushan, representing petitioner Jacob Puliyel, vehemently argued that there is evidence in the medical literature that, vaccines that have not been adequately tested for safety or efficacy are now licensed under emergency use authorization without the data being disclosed to the public. Bhushan emphasized coercive mandates for use of these inadequately…
Read More
Covaxin, Covishield mixing: Cocktail vaccine safe, provides better immunity against Covid-19 variants | ICMR study

Covaxin, Covishield mixing: Cocktail vaccine safe, provides better immunity against Covid-19 variants | ICMR study

The Indian Council of Medical Research (ICMR) on Sunday said a study conducted by it on mixing and matching COVID-19 vaccines, Covaxin and Covishield demonstrated better results in building immunity against the coronavirus. Carried out between May and June this year in Uttar Pradesh, the study suggests that iummunisation with combination of an adenovirus vector platform-based vaccine followed by inactivated whole virus vaccine was not only safe but also elicited better immunogenicity. "Such mixed regimens will also help to overcome the challenges of shortfall of particular vaccines and remove hesitancy around vaccines in people's mind that could have genesis in…
Read More
India sees single-day rise of 38,628 Covid-19 cases, 617 deaths

India sees single-day rise of 38,628 Covid-19 cases, 617 deaths

India recorded a single-day rise of 38,628 new coronavirus cases, taking the infection tally to 3,18,95,385, while the death toll climbed to 4,27,371 with 617 fresh fatalities, the Union health ministry said on Saturday. The active cases in the country have declined to 4,12,153 and comprise 1.29 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 97.37 per cent, the ministry data updated at 8 am showed.A decrease of 2,006 cases has been recorded in the active COVID-19 caseload in a span of 24 hours, it said. The ministry also said that 17,50,081 tests…
Read More
J&J’s single-dose Covid vaccine gets Emergency Use approval in India

J&J’s single-dose Covid vaccine gets Emergency Use approval in India

Johnson & Johnson’s single-dose Covid-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said on Saturday. He said this will further boost the country’s collective fight against the novel coronavirus infection. “India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has five EUA vaccines. This will further boost our nation’s collective fight against #COVID19,” the minister tweeted. “The US-based pharmaceutical company had applied for Emergency Use Authorisation for its jab on Friday and was granted the approval the same day by the…
Read More
Johnson & Johnson applies for emergency use authorisation of its single-dose Covid-19 vaccine in India

Johnson & Johnson applies for emergency use authorisation of its single-dose Covid-19 vaccine in India

Global healthcare major Johnson & Johnson today said it has applied for Emergency Use Authorisation (EUA) of its single-dose COVID-19 vaccine in India.On Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021, Johnson & Johnson Pvt. Ltd applied for Emergency Use Authorisation (EUA) of its single-dose covid-19 vaccine to the Government of India," read the statement. Johnson & Johnson claimed that its single-shot vaccine, in clinical trials, proved to be 85 per cent effective in preventing severe disease.…
Read More
SpiceHealth’s mobile testing laboratory in Guwahati

SpiceHealth’s mobile testing laboratory in Guwahati

To conduct Real-Time Polymerase Chain Reaction (RT-PCR) and Rapid Antigen tests, SpiceHealth has launched its first mobile testing laboratory in Guwahati. The Company’s mobile lab will be stationed at the Indira Gandhi Athletic Stadium whereas the sample collection set-up will be at Lokpriya Gopinath Bordoloi International Airport. SpiceHealth has partnered with National Health Mission, Assam to set-up the facility in Guwahati. SpiceHealth operates 23 labs and collection centers spread across ten cities in India. The Company operates seven vaccination centers in five states. SpiceHealth has emerged as the fastest growing diagnostic lab in the country having conducted 3.5 million RT-PCR…
Read More